ZHEJIANG HUAKANG PHARMACEUTICAL CO., LTD.

Zhejiang Huakang Pharmaceutical Co., Ltd.

605077

CNE100005477

Food Processing

End-of-day quote Shanghai S.E. Other stock markets 23:00:00 21/05/2024 BST			5-day change	1st Jan Change
23.45 ^CNY	-1.80%		+0.39%	+8.36%

04-18	Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
02-10	Certain A Shares of Zhejiang Huakang Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 10-FEB-2024.	CI

Zhejiang Huakang Pharmaceutical Co., Ltd.(XSSC:605077) added to S&P Global BMI Index

September 18, 2023 at 05:00 am

Latest news about Zhejiang Huakang Pharmaceutical Co., Ltd.

Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	04-18	CI
Certain A Shares of Zhejiang Huakang Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 10-FEB-2024.	02-09	CI
Zhoushan Huakang Biotechnology Co., Ltd. announced that it expects to receive CNY 700 million in funding from Zhejiang Huakang Pharmaceutical Co., Ltd.	01-02	CI
Huakang Pharmaceutical Earmarks 248 Million Yuan for Corn Oil, Maltodextrin Plants	25/10/23	MT
Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	24/10/23	CI
Zhejiang Huakang Pharmaceutical Co., Ltd.(XSSC:605077) added to S&P Global BMI Index	18/09/23	CI
Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	29/08/23	CI
HY Energy Plans to Sell Remaining Stake in Huakang Pharma	01/08/23	CI
Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	27/04/23	CI
Zhejiang Huakang Pharma Selling 1.3 Billion Yuan Convertible Bonds to Fund New Factory	24/03/23	MT
Zhejiang Huakang Pharmaceutical Co., Ltd. (SHSE:605077completed the acquisition of 95% each on Zhejiang Huahe Thermal Power Co., Ltd. and Zhoushan Xinyisheng Trading Co., Ltd. from Ningbo Ruishunjiu Trading Co., Ltd.	08/01/23	CI
Zhejiang Huakang Pharma to Buy 95% of Thermal Power Firm for 522.5 Million Yuan	29/12/22	MT
Zhejiang Huakang Pharmaceutical Co., Ltd. agreed to sign the Equity Transfer Agreement to acquire 95% each on Zhejiang Huahe Thermal Power Co., Ltd. and Zhoushan Xinyisheng Trading Co., Ltd. from Ningbo Ruishunjiu Trading Co., Ltd. for CNY 522.5 million.	28/12/22	CI
Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	26/10/22	CI
HY Energy Plans to Unload Stake in Zhejiang Huakang Pharma	26/09/22	CI
Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	10/08/22	CI
Jiaozuo Huakang Sugar Alcohol Technology Co., Ltd. announced that it expects to receive CNY 295.8671 million in funding from Zhejiang Huakang Pharmaceutical Co., Ltd.	26/06/22	CI
Ningbo Traditional Chinese Pharmaceutical Corp. announced that it has received CNY 21.97644 million in funding from Zhejiang Huakang Pharmaceutical Co., Ltd.	23/05/22	CI
Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	27/04/22	CI
Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	19/04/22	CI
Zhejiang Huakang Pharmaceutical Co., Ltd.(SHSE:605077) added to Shanghai Stock Exchange Composite Index	24/02/22	CI
Zhejiang Huakang Pharmaceutical Co., Ltd.(SHSE:605077) added to Shanghai Stock Exchange A Share Index	24/02/22	CI
Certain A Shares of Zhejiang Huakang Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 10-FEB-2022.	09/02/22	CI
Gaomi Tongli Sugar Co., Ltd. announced that it expects to receive CNY 20 million in funding from Zhejiang Huakang Pharmaceutical Co., Ltd.	09/01/22	CI
Ningbo Traditional Chinese Pharmaceutical Corp. announced that it expects to receive CNY 21.97644 million in funding from Zhejiang Huakang Pharmaceutical Co., Ltd.	05/01/22	CI

Chart Zhejiang Huakang Pharmaceutical Co., Ltd.

Duration

Period

Chart Zhejiang Huakang Pharmaceutical Co., Ltd.

More charts

Zhejiang Huakang Pharmaceutical Co Ltd is a China-based company mainly engaged in the research and development, production and sales of a variety of functional sugar alcohols and starch sugar products. The Company's main products are xylitol, sorbitol, maltitol and grape syrup. Its products are mainly used in food, beverage, daily chemical and other fields. The Company conducts its businesses within the China market and to overseas markets such as Europe, America and Asia.

Sector

Food Processing

Calendar

14/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

23.45 CNY

Average target price

25 CNY

Spread / Average Target

+6.61%

Consensus

Annual profits - Rate of surprise

Company calendar

Sector Food Ingredients

	1st Jan change	Capi.
ZHEJIANG HUAKANG PHARMACEUTICAL CO., LTD.	+8.36%	740M
FOSHAN HAITIAN FLAVOURING AND FOOD COMPANY LTD.	-0.11%	29.08B
INTERNATIONAL FLAVORS & FRAGRANCES INC.	+18.33%	24.5B
KIKKOMAN CORPORATION	+5.98%	11.04B
LANCASTER COLONY CORPORATION	+12.66%	5.19B
MEIHUA HOLDINGS GROUP CO.,LTD	+18.12%	4.44B
ANGEL YEAST CO., LTD	-9.01%	3.79B
TATE & LYLE PLC	+7.36%	3.43B
JONJEE HI-TECH INDUSTRIAL AND COMMERCIAL HOLDING CO.,LTD	-1.10%	2.94B
KEWPIE CORPORATION	+23.69%	2.75B

Food Ingredients